Abstract:Paclitaxel, the first member of taxanes, is one of the most active chemotherapeutic agents developed in the last decade for the treatment of advanced breast cancer and many other types of solid tumors. The promising clinical activity of paclitaxel has also promoted considerable interest in combining this drug with other anti-tumor agents. In this study, we assessed the cytotoxic interaction between paclitaxel and gemcitabine administered at various schedules to human breast and ovarian cancer cells. Through a series of in vitro assays including 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, DNA fragmentation, and flow cytometric analyses, we found that gemcitabine could significantly antagonize the cytotoxic effects of paclitaxel when tumor cells were exposed to the two drugs simultaneously or exposed to gemcitabine before paclitaxel. However, there was little antagonistic interaction observed when paclitaxel was administered before gemcitabine. Further analyses demonstrated that gemcitabine could significantly interfere with the cytotoxic effects of paclitaxel on both mitotic arrest and apoptotic cell death unless paclitaxel is administered before gemcitabine. In addition, biochemical examinations revealed that pretreatment or cotreatment of gemcitabine inhibited paclitaxel-induced I kappa B alpha degradation and bcl-2 phosphorylation that are believed to play critical roles in the signal pathways leading to apoptotic cell death. These results indicate that the interaction between paclitaxel and gemcitabine is highly schedule dependent. Exposure of tumor cells to gemcitabine before paclitaxel or two drugs simultaneously could result in pronounced antagonism. The optimal schedule for this combination might be sequential exposure to paclitaxel followed by gemcitabine.

The Combination Effect of Gemcitabine with Mitomycin on Human Lung Cancer A549 Cell Line in Vitro

Effect of 5-Azn-2'-deoxycytidine on Proliferation of Human Lung Adenocarcinoma Cell Line A549 in Vitro

The preliminary study on effect of targeting drugs on human non-small cell lung cancer A549 cells in vitro and quantification of iodine with Gemstone Spectral Imaging

The effects of Gemcitabine in human non-small cell lung cancer A549 and H1299 cells proliferation and apoptosis

Inhibition of Expression of Vascular Endothelial Growth Factor and Its Receptors in Pulmonary Adenocarcinoma Cell by TNP-470 in Combination with Gemcitabine

The killing effect of rmhTNF-α combined with gemcitabine on human lune adenocarcinoma cells A549

Effect of Gemcitabine in Combination with Etoposide on Human Ovarian Cancer 3AO Cell Line

Effects of Combination of Gefitinib and Docetaxel on Various Tumor Cell Lines in Vitro

Mechanistic Study of the Effects of Different Dosages of Gemcitabine on the Migratory and Invasive Abilities of Lung Adenocarcinoma A549 Cells

TNP-470 Combined with Gemcitabine Inhibits the Expression of Vascular Endothelial Cell Growth Factor and Its Receptors in Human Pulmonary Adenocarcinoma Cells and Umbilical Vein Endothelium Cells

The effect of Gemcitabine on pancreatic cancer PC-2 cells growth and gene expression

Combination of Cetuximab and Gefitinibto Therapy Non-Small Cell Lung Cancer(nsclc) in Vitro

Effect of Gemcitabine on Proliferation, Apoptosis and Polo-Like Kinase-1 Expression of Pancreatic Cancer Cell Line AsPC-1

The Cytotoxic Effect,cell Cycle Perturbations and Apoptosis by Gemcitabine in Human Bladder Cancer Lines

Data from Synergistic Antitumor Activity of Gemcitabine and ABT-737 <i>In Vitro and In Vivo</i> through Disrupting the Interaction of USP9X and Mcl-1

Inhibiting Effect of Mitomycin C on Human Nasopharyngeal Carcinoma Cell Line HNE2、HNE2/lmp1 and Its Mechanism

Gemcitabine‑fucoxanthin Combination in Human Pancreatic Cancer Cells

Synergistic Effects of Nanosecond Pulsed Electric Fields Combined with Low Concentration of Gemcitabine on Human Oral Squamous Cell Carcinoma in Vitro

Effect of Autophagy on Gemcitabine-induced A549 Lung Cancer Cell Death and Relevant Mechanisms

Synergistic Effect of Gefitinib and Cisplatin on Proliferation of Lung Cancer Cell Line

Combination of Gemcitabine Antagonizes Antitumor Activity of Paclitaxel Through Prevention of Mitotic Arrest and Apoptosis